Innovation Pharmaceuticals Inc. Financial Ratios — IPIX

Profitability (USD)

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	06/30/2009	06/30/2010	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	-319.44	-257.35	- -	- -	- -	- -	-309.26	-115.06	-93.6
Return on Assets (%)	-491.01	-2,671.36	-2,862.42	-2,869.35	-215.07	-119.33	-104.45	-99.77	-151.15	-209.06	-163.99	-100.02	-117.82	-57.06	-35.4
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	100	- -	100	- -
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1,007.57	- -	-35,422.22	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1,095.74	- -	-37,544.44	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,035.46	- -	-21,216.67
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1,571.63	- -	-39,116.67	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1,571.63	- -	-39,116.67	- -
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1,571.63	- -	-39,116.67	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	1.33	6.17	19.36	- -	- -	- -	- -	- -	- -	- -	- -	-2.71
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	-319.44	-257.35	- -	- -	- -	- -	-309.26	-115.06	-96.14

Credit (USD)

Credit Ratios API ChatGPT

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	06/30/2009	06/30/2010	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023

Total Debt	- -	- -	1	- -	2	2	2	2	2	2	2	2	2	1	- -
ST Debt	- -	- -	- -	- -	2	2	2	2	2	2	2	2	2	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	-0.3	-0.14	-0.09	- -	-0.68	-0.26	-0.16	-0.17	-0.14	-0.15	-0.32	-0.58	-0.22	-0.08	-0.1
Net Debt/EBITDA	-0.2	-0.14	-0.08	0.01	0.31	0.38	0.51	0.37	0.14	0.03	-0.22	0.97	1.01	0.56	0.51
Total Debt/EBIT	-0.3	-0.14	-0.09	- -	-0.68	-0.25	-0.16	-0.17	-0.13	-0.15	-0.3	-0.53	-0.21	-0.07	-0.09
Net Debt/EBIT	-0.2	-0.14	-0.08	0.01	0.31	0.37	0.49	0.36	0.14	0.03	-0.21	0.89	0.97	0.53	0.44
EBITDA to Interest Expense	- -	-48.52	-26.5	-16.33	-12.37	-36.9	-62.14	-57.36	-73.92	-66.98	-2.77	-16.39	-1.78	-55.44	-45.02
EBITDA-CapEx/Interest Expense	- -	-48.52	-26.5	-16.33	-12.42	-49.63	-64.41	-59.41	-75.58	-67.56	-2.81	-16.74	-1.79	-55.44	-45.02
EBIT to Interest Expense	- -	-48.52	-26.5	-16.33	-12.38	-38.28	-64.14	-59.44	-75.92	-69.02	-2.94	-17.83	-1.86	-58.77	-51.56
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	- -	5	- -	- -
Common Equity/Total Assets	-1,155.08	-4,711.86	-2,327.75	-27,208.5	-174.07	11.11	49.05	25.9	-16.07	-32.88	-102.05	15.81	52.51	45.57	27.13
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	28.52	3.36	1.16	- -
Long-Term Debt/Capital (%)	- -	- -	-5.16	- -	- -	- -	- -	- -	- -	- -	- -	10.64	2.69	1.05	- -
Long-Term Debt/Total Assets (%)	- -	- -	111.54	- -	- -	- -	- -	- -	- -	- -	- -	4.51	1.76	0.53	- -
Total Debt/Equity (%)	-24.11	-9.59	-7.08	- -	-39.11	167.66	28.79	68.22	-138.11	-94	-46.55	167.99	24.93	10.61	13.14
Total Debt/Capital (%)	-31.77	-10.6	-7.62	- -	-64.23	62.64	22.35	40.55	362.37	-1,567.44	-87.09	62.69	19.96	9.59	11.62
Total Debt/Total Assets (%)	278.49	451.78	164.91	- -	68.08	18.63	14.12	17.67	22.19	30.91	47.5	26.56	13.09	4.84	3.57
Net Debt to Equity	-16.28	-9.5	-6.14	0.36	18.05	-245.94	-90.95	-144.67	144.74	18.69	-32.53	-281.6	-116.38	-75.2	-64
Net Debt/Capital (%)	-19.45	-10.5	-6.54	0.36	15.29	168.52	-1,004.4	323.87	59.14	15.75	-48.21	196.05	1,074.91	-249.61	-165.4
EBITDA	-1	-3	-6	-4	-3	-8	-13	-12	-15	-14	-6	-4	-9	-6	-3
EBITDA-CapEx	-1	-3	-6	-4	-3	-10	-13	-12	-15	-14	-6	-4	-9	-6	-3
Operating Income (Loss)	-1	-3	-6	-4	-3	-8	-13	-12	-15	-14	-6	-5	-9	-7	-3

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	06/30/2009	06/30/2010	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023

Cash Ratio	0.07	- -	0.01	- -	0.36	0.52	1.15	0.74	0.39	0.28	0.08	0.82	1.56	0.79	0.3
Current Ratio	0.08	0.02	0.05	- -	0.36	0.58	1.2	0.78	0.42	0.3	0.09	0.83	1.63	0.82	0.33
Quick Ratio	0.07	- -	0.04	- -	0.36	0.52	1.15	0.75	0.39	0.28	0.08	0.82	1.56	0.79	0.3
CFO/Avg Current Liab	-0.18	-0.32	-0.13	-0.1	-0.25	-0.84	-1.54	-1.25	-1.23	-1.38	-0.79	-0.57	-1.37	-1.11	-0.43
Common Equity/Total Assets	-1,155.08	-4,711.86	-2,327.75	-27,208.5	-174.07	11.11	49.05	25.9	-16.07	-32.88	-102.05	15.81	52.51	45.57	27.13
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	28.52	3.36	1.16	- -
Long-Term Debt/Capital (%)	- -	- -	-5.16	- -	- -	- -	- -	- -	- -	- -	- -	10.64	2.69	1.05	- -
Long-Term Debt/Total Assets (%)	- -	- -	111.54	- -	- -	- -	- -	- -	- -	- -	- -	4.51	1.76	0.53	- -
Total Debt/Equity (%)	-24.11	-9.59	-7.08	- -	-39.11	167.66	28.79	68.22	-138.11	-94	-46.55	167.99	24.93	10.61	13.14
Total Debt/Capital (%)	-31.77	-10.6	-7.62	- -	-64.23	62.64	22.35	40.55	362.37	-1,567.44	-87.09	62.69	19.96	9.59	11.62
Total Debt/Total Assets (%)	278.49	451.78	164.91	- -	68.08	18.63	14.12	17.67	22.19	30.91	47.5	26.56	13.09	4.84	3.57
CFO/Total Liabilities	-10.85	-22.64	-9.68	-9.07	-23.43	-77.86	-179.18	-116.58	-110.73	-152.76	-77.46	-53.38	-139.84	-111.17	-38.44
CFO/CapEx	- -	- -	- -	- -	-173.36	-2.81	-28.48	-23.88	-34.85	-113.49	-73.63	-45.67	-131.88	- -	- -
Altman's Z-Score	-51.63	-234.27	-130.88	-1,622.59	-12.44	-0.59	14.39	-4.32	-24.33	-56.23	-226.94	-15.1	-7.84	-22.43	-33.16

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	06/30/2009	06/30/2010	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023

Accounts Receivable Turnover

- -

Days Sales Outstanding

- -

Inventory Turnover

- -

Days Inventory Outstanding

- -

Accounts Payable Turnover

- -

Accounts Payable Turnover Days

- -

Cash Conversion Cycle

- -

Inventory to Cash Days

- -

Inventories

- -

Raw Materials

- -

Work In Process

- -

Finished Goods

- -

Other Inventory

- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	06/30/2009	06/30/2010	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023

Market Capitalization	35	50	64	30	32	183	304	172	130	96	38	136	93	16	10
- Cash & Cash Equivalents	- -	- -	- -	- -	3	5	8	6	4	2	1	6	10	4	2
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	1	- -	2	2	2	2	2	2	2	2	2	1	- -
Enterprise Value	35	50	64	29	31	180	297	168	128	96	39	132	85	12	9
Total Capital	-1	-4	-7	-8	-3	3	9	5	1	- -	-2	4	9	5	2
Total Debt/Capital (%)	-31.77	-10.6	-7.62	- -	-64.23	62.64	22.35	40.55	362.37	-1,567.44	-87.09	62.69	19.96	9.59	11.62
Total Debt / EV	0.01	0.01	0.01	- -	0.07	0.01	0.01	0.01	0.02	0.02	0.05	0.02	0.02	0.04	0.03
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	312.4	- -	684.16	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	35	50	66	29	30	175	297	167	122	85	33	98	83	16	10
Diluted Enterprise Value	35	50	66	29	29	172	291	162	120	85	35	94	75	12	9
EV per Share	0.38	0.54	0.74	0.32	0.31	1.64	2.53	1.36	0.94	0.59	0.19	0.4	0.2	0.02	0.02
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	-1	-3	-6	-4	-3	-8	-13	-12	-15	-14	-6	-4	-9	-6	-3
TTM Operating Income	-1	-3	-6	-4	-3	-8	-13	-12	-15	-14	-6	-5	-9	-7	-3
TTM Cash Flow to Firm	- -	-1	-1	- -	-2	-7	-13	-10	-12	-13	-4	-4	-5	-6	-2
TTM Free Cash Flow to Firm	- -	-1	-1	- -	-2	-5	-12	-9	-11	-13	-4	-4	-5	-6	-2

Multiples (USD)

Valuation Multiples API ChatGPT

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	06/30/2009	06/30/2010	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023

Price/Free Cash Flow	-165.03	-44.72	-89.6	-41.57	-16.03	-36.27	-23.54	-17.59	-10.74	-6.48	-5.34	-24.05	-8.83	-2.49	-4.8
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	35	50	64	29	31	180	297	168	128	96	39	132	85	12	9
Low Price	0.15	0.23	0.1	0.25	0.3	0.3	1.6	0.94	0.63	0.32	0.07	0.05	0.16	0.02	0.01
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	312.4	- -	684.16	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-22.32	-11.82	-7.93	-6.78	-8.85	-14.57	-25.8	-15.18	-9.02	-5.88	-4.65	-4.55	-6.67	-9.11	-4.18
Price/Earnings High	-61.83	-27.02	-15.36	-14.54	-9.12	-21.67	-43.16	-34.05	-12.33	-10.33	-13.14	-23.31	-13.92	-38.64	-10.36
Price/Earnings Low	-9.27	-6.15	-1.52	-4.54	-8.29	-3.08	-14.01	-8.78	-5.16	-2.87	-1.44	-1.79	-4.31	-1.37	-1.77
Price/Book Value	-19.46	-10.35	-8.77	-3.87	-6.13	152.03	43.26	57.96	-88.7	-44.74	-9.21	92.82	12.45	3.3	5.08
Price/Book Value Average	-18.49	-8.46	-6.26	-4.51	-6.13	129.15	49.4	67.85	-101.75	-50.5	-11.16	28.71	13.85	13.56	6.65
Price/Book Value High	-51.22	-19.36	-12.14	-9.67	-6.32	192.08	82.66	152.19	-139.06	-88.72	-31.51	147.16	28.89	57.52	16.5
Price/Book Value Low	-7.68	-4.41	-1.2	-3.02	-5.75	27.31	26.83	39.25	-58.21	-24.64	-3.45	11.32	8.95	2.05	2.82
Price/Tangible Book Value	-19.46	-10.35	-8.77	-3.87	-6.12	-48.81	151.46	-127.53	-22.88	-16.23	-5.09	-84.92	19.66	6.46	259.17
Price/Tangible Book Value Average	-18.49	-8.46	-6.26	-4.51	-6.12	-41.47	172.99	-149.3	-26.24	-18.32	-6.17	-26.27	21.87	26.52	338.97
Price/Tangible Book Value High	-51.22	-19.36	-12.14	-9.67	-6.31	-61.67	289.42	-334.89	-35.87	-32.18	-17.42	-134.63	45.61	112.53	841.02
Price/Tangible Book Value Low	-7.68	-4.41	-1.2	-3.02	-5.74	-8.77	93.93	-86.36	-15.01	-8.94	-1.9	-10.36	14.14	4	143.84
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	231.11	- -	867.77	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	71.49	- -	3,562.08	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	366.39	- -	15,116.01	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	28.18	- -	537.46	- -
Price/Cash Flow	-165.03	-44.72	-89.6	-41.57	-15.94	-23.36	-22.72	-16.86	-10.43	-6.42	-5.26	-23.52	-8.76	-2.49	-4.8
Price/Cash Flow Average	-156.74	-36.58	-63.99	-48.48	-15.94	-19.84	-25.94	-19.73	-11.97	-7.25	-6.38	-7.28	-9.75	-10.21	-6.28
Price/Cash Flow High	-434.28	-83.64	-123.97	-103.93	-16.44	-29.51	-43.41	-44.27	-16.36	-12.73	-18.01	-37.29	-20.34	-43.33	-15.59
Price/Cash Flow Low	-65.14	-19.05	-12.27	-32.48	-14.94	-4.2	-14.09	-11.41	-6.85	-3.54	-1.97	-2.87	-6.3	-1.54	-2.67
Price/Free Cash Flow Average	-156.74	-36.58	-63.99	-48.48	-16.03	-30.82	-26.89	-20.6	-12.32	-7.31	-6.47	-7.44	-9.82	-10.21	-6.28
Price/Free Cash Flow High	-434.28	-83.64	-123.97	-103.93	-16.53	-45.83	-44.99	-46.2	-16.84	-12.85	-18.26	-38.13	-20.49	-43.33	-15.59
Price/Free Cash Flow Low	-65.14	-19.05	-12.27	-32.48	-15.03	-6.52	-14.6	-11.91	-7.05	-3.57	-2	-2.93	-6.35	-1.54	-2.67
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	90.82	- -	3,378.46	- -
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	500.19	- -	14,932.4	- -
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	30.7	- -	353.85	- -
EV/EBITDA Average	-23.36	-12.21	-8.06	-8.19	-10.32	-19.72	-27.14	-16.99	-9.83	-8	-7.8	-9.01	-11.08	-9.54	-4.8
EV/EBITDA High	-64.36	-27.74	-15.54	-17.57	-10.65	-29.51	-45.74	-38.56	-13.49	-14.07	-21.62	-49.64	-24.15	-42.16	-12.62
EV/EBITDA Low	-9.83	-6.42	-1.61	-5.49	-9.65	-3.87	-14.5	-9.67	-5.57	-3.89	-2.56	-3.05	-6.82	-1	-1.76
EV/EBIT Average	-23.36	-12.21	-8.06	-8.19	-10.32	-19.01	-26.29	-16.39	-9.58	-7.76	-7.35	-8.29	-10.61	-9	-4.19
EV/EBIT High	-64.36	-27.74	-15.54	-17.57	-10.65	-28.45	-44.32	-37.22	-13.14	-13.66	-20.38	-45.65	-23.14	-39.77	-11.02
EV/EBIT Low	-9.83	-6.42	-1.61	-5.49	-9.65	-3.73	-14.05	-9.33	-5.42	-3.77	-2.41	-2.8	-6.54	-0.94	-1.53
Last Price	0.38	0.54	0.73	0.32	0.32	1.67	2.58	1.39	0.96	0.59	0.19	0.41	0.22	0.03	0.02
High Price	1	1.01	1.01	0.8	0.33	2.11	4.93	3.65	1.5	1.17	0.64	0.65	0.5	0.54	0.06
Enterprise Value Average	33	41	46	34	31	153	341	197	147	108	47	38	96	61	12
Enterprise Value High	92	93	89	74	32	229	574	447	201	190	131	212	209	269	32
Enterprise Value Low	14	22	9	23	29	30	182	112	83	53	16	13	59	6	5

Shares Outstanding	92	92	88	92	99	110	118	124	135	163	203	331	434	504	518
Diluted Weighted Avg Shares	92	92	90	90	95	105	115	120	127	145	178	238	386	504	506
Basic Weighted Avg Shares	92	92	90	90	95	105	115	120	127	145	178	238	386	504	506
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	-0.02	-0.04	-0.06	-0.05	-0.03	-0.07	-0.11	-0.1	-0.12	-0.09	-0.03	-0.02	-0.02	-0.01	-0.01
Operating Income per Share	-0.02	-0.04	-0.06	-0.05	-0.03	-0.08	-0.11	-0.1	-0.12	-0.1	-0.04	-0.02	-0.02	-0.01	-0.01
Basic EPS, GAAP	-0.02	-0.04	-0.07	-0.06	-0.04	-0.1	-0.11	-0.11	-0.12	-0.11	-0.05	-0.03	-0.04	-0.01	-0.01
Basic EPS from Cont Ops	-0.02	-0.04	-0.07	-0.05	-0.03	-0.08	-0.11	-0.11	-0.12	-0.11	-0.05	-0.03	-0.04	-0.01	-0.01
Diluted EPS, GAAP	-0.02	-0.04	-0.07	-0.06	-0.04	-0.1	-0.11	-0.11	-0.12	-0.11	-0.05	-0.03	-0.04	-0.01	-0.01
Diluted EPS from Cont Ops	-0.02	-0.04	-0.07	-0.05	-0.03	-0.08	-0.11	-0.11	-0.12	-0.11	-0.05	-0.03	-0.04	-0.01	-0.01
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	-0.01	-0.01	-0.01	-0.02	-0.07	-0.11	-0.08	-0.09	-0.09	-0.04	-0.02	-0.02	-0.01	- -
Free Cash Flow per Basic Share	- -	-0.01	-0.01	-0.01	-0.02	-0.1	-0.12	-0.09	-0.09	-0.09	-0.04	-0.02	-0.02	-0.01	- -
Cash & Equivalents per Share	- -	- -	- -	- -	0.03	0.05	0.07	0.05	0.03	0.01	- -	0.02	0.02	0.01	- -
Book Value per Share	-0.02	-0.05	-0.08	-0.08	-0.05	0.01	0.06	0.02	-0.01	-0.01	-0.02	- -	0.02	0.01	- -
Tangible Book Value per Share	-0.02	-0.05	-0.08	-0.08	-0.05	-0.03	0.02	-0.01	-0.04	-0.04	-0.04	- -	0.01	- -	- -

Innovation Pharmaceuticals Inc.